高龄非典型脑膜瘤患者的最佳治疗方案:基于美国国家癌症数据库(NCDB)的生存结局分析
本研究基于美国国家癌症数据库,纳入65岁以上经手术切除的颅内非典型脑膜瘤患者,比较老年(65-80岁)与高龄(>80岁)患者的生存结局。多因素分析显示,次全切除与较差生存相关(HR 1.28,p<0.01),放疗与改善生存相关(HR 0.76,p<0.01),全身治疗与生存改变无关(HR 1.17,p=0.79)。亚组分析中,放疗对65-80岁患者未与改善生存相关(HR 0.85,p=0.11),但对>80岁患者与改善生存相关(HR 0.51,p<0.01)。
要点
- 高龄(>80岁)非典型脑膜瘤患者接受放疗比例(14.13%)低于老年(65-80岁)患者(26.50%)。
- 次全切除与较差生存相关(HR 1.28,p<0.01),放疗与改善生存相关(HR 0.76,p<0.01)。
- 放疗对>80岁患者与改善生存相关(HR 0.51,p<0.01),对65-80岁患者未达统计学显著(HR 0.85,p=0.11)。
核心结论
- 全切除在老年和高龄队列中均提供生存优势。
- 放疗为高龄患者提供生存获益,尽管高龄患者接受放疗的可能性较低。
- 高龄患者可能从非典型脑膜瘤的更积极治疗中获益。
研究设计与样本
- 基于美国国家癌症数据库(NCDB)的回顾性分析,纳入65岁以上经手术切除的颅内非典型脑膜瘤患者。
- 共纳入1747例老年患者(65-80岁)和382例高龄患者(>80岁)。
- 采用Cox比例风险模型评估手术切除类型、放疗和全身治疗与总生存的关联,并控制性别、种族、民族、机构类型、收入、肿瘤大小和CDCC评分。
主要发现
- 61.70%老年患者和58.90%高龄患者接受全切除。
- 26.50%老年患者和14.13%高龄患者接受放疗。
- 多因素分析中,次全切除与较差生存相关(HR 1.28,p<0.01),放疗与改善生存相关(HR 0.76,p<0.01)。
- 全身治疗与生存改变无关(HR 1.17,p=0.79)。
- 亚组分析中,全切除在老年和高龄队列中均与较好生存相关;放疗对65-80岁患者未与改善生存相关(HR 0.85,p=0.11),对>80岁患者与改善生存相关(HR 0.51,p<0.01)。
临床怎么用
- 作者认为高龄患者可能从更积极的治疗中获益,包括全切除和放疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We assess the efficacy of different surgical resection types, radiotherapy, systemic therapy on overall survival in very elderly patients (age > 80) with intracranial atypical meningioma in contrast with their elderly (65-80) counterparts. METHODS: Patients > 65 years old with intracranial atypical meningiomas surgically resected and catalogued via the National Cancer Database were included. Cox proportional hazards models were developed to assess the association between surgical resection type, radiotherapy and systemic therapy with OS while controlling for sex, race, ethnicity, facility type, income, tumor size and CDCC score. RESULTS: 1747 elderly patients and 382 very elderly patients were included. 61.70% elderly patients and 58.90% very elderly patients received GTR. 26.50% elderly patients and 14.13% very elderly patients received radiotherapy. In multivariate analysis, subtotal resection is associated with worse survival (HR 1.28, p < 0.01) and radiotherapy is associated with improved survival (HR 0.76, p < 0.01). Systemic therapy was not associated with changes in survival outcomes (HR 1.17, p = 0.79). Using subgroup analysis, gross total resection is associated with better survival outcomes in both elderly and very elderly cohorts. Radiotherapy was not associated with improved survival (HR 0.85, p = 0.11) for patients between 65 and 80 years old, but was associated with improved survival (HR 0.51, p < 0.01) for patients > 80 years old. CONCLUSION: GTR provides survival advantage in both elderly and very elderly cohorts. Radiotherapy provides survival benefits for very elderly patients even though very elderly patients are less likely to received radiotherapy. Very elderly patients may benefit from more aggressive management in the treatment of atypical meningiomas.
引用
- Tang L, Chakravarti S, Li E, et al. Optimal treatment regimen for very elderly patients with atypical meningioma: an analysis of survival outcomes using the National Cancer Database (NCDB). J Neurooncol. 2024. PMID: 39560694. doi:10.1007/s11060-024-04886-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。